Immatics Raises €54 Million Series C To Fund Pivotal Therapeutic Cancer Vaccine Trial
This article was originally published in The Pink Sheet Daily
Executive Summary
One of the largest European fundraisings this year, the round will help advance a potential therapeutic vaccine for kidney cancer through Phase III.